Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $1.1 billion.

  • Phibro Animal Health's Total Liabilities rose 332.0% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 332.0%. This contributed to the annual value of $1.1 billion for FY2025, which is 4819.49% up from last year.
  • Latest data reveals that Phibro Animal Health reported Total Liabilities of $1.1 billion as of Q4 2025, which was up 332.0% from $1.1 billion recorded in Q3 2025.
  • In the past 5 years, Phibro Animal Health's Total Liabilities registered a high of $1.1 billion during Q2 2025, and its lowest value of $589.1 million during Q1 2021.
  • Moreover, its 5-year median value for Total Liabilities was $693.3 million (2022), whereas its average is $766.6 million.
  • As far as peak fluctuations go, Phibro Animal Health's Total Liabilities soared by 85.06% in 2023, and later soared by 5172.37% in 2025.
  • Phibro Animal Health's Total Liabilities (Quarter) stood at $609.7 million in 2021, then increased by 13.75% to $693.5 million in 2022, then rose by 1.22% to $701.9 million in 2023, then skyrocketed by 47.98% to $1.0 billion in 2024, then rose by 3.32% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, $1.1 billion for Q3 2025, and $1.1 billion during Q2 2025.